Company profile: Miromatrix
1.1 - Company Overview
Company description
- Provider of fully biological human organs and organ-derived products to address the transplant shortage, using patented perfusion decellularization/recellularization technology, plus PAH therapy and patient support via Remodulin (IV/SC), ASSIST, Archways for inhaled/oral treprostinil, and an Expanded Access Program.
Products and services
- Remodulin: A parenteral, prescription-grade medication that treats adults with pulmonary arterial hypertension, available in intravenous and subcutaneous forms to flexibly match clinical administration needs
- Expanded Access Program: A compassionate-use channel that delivers investigational drugs to patients with serious or life-threatening conditions lacking options and ineligible for clinical trials
- ASSIST: A reimbursement-focused, patient-support program that helps patients and customers navigate access to United Therapeutics medicines, including coverage, reimbursement, and product distribution questions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Miromatrix
Fantex
HQ: United Kingdom
Website
- Description: Provider of polymeric biocide technology designed to combat bacteria and infectious diseases. Fantex technology represents a new generation and class of biocides that exploit natural bio-defence-mimetics and work differently from chemical biocides by using a novel method of bacterial cell killing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fantex company profile →
Caliper Life Sciences
HQ: United States
Website
- Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caliper Life Sciences company profile →
bit.bio
HQ: United Kingdom
Website
- Description: Provider of proprietary cell programming technology and human iPSC-derived cell products for research and drug discovery. Bit.bio develops opti-ox to convert iPSCs into mature, functional human cells and offers ioCells for consistent, scalable supply. The company applies computational principles to biology to code cells for health, including collaboration with The Michael J. Fox Foundation on Parkinson’s research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full bit.bio company profile →
Kreatech Diagnostics
HQ: The Netherlands
Website
- Description: Provider of innovative detection products for diagnostic and research applications in the life sciences and healthcare industries, focused on molecular diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kreatech Diagnostics company profile →
Hamilton Thorne
HQ: United States
Website
- Description: Provider of advanced laser systems and instruments for in-vitro cell applications in regenerative medicine research and fertility clinic markets. Offerings include ZILOS-tk and XYClone lasers that attach to inverted microscopes and act as robotic micro-surgeons; sperm analyzers and CASA platforms (IVOS II, TOX IVOS II), IVF equipment, and ZANDAIR PCOC3 in-duct air purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hamilton Thorne company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Miromatrix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Miromatrix
2.2 - Growth funds investing in similar companies to Miromatrix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Miromatrix
4.2 - Public trading comparable groups for Miromatrix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →